PTHL (ftzy.com.cn) Multiplikator Forward P/S

Simbol lan logo merek Pheton (PTHL)

Pheton Holdings Ltd generates revenue through the implementation of radiotherapy software, while the deep integration of IT systems within clinics ensures subscription stability. The forward price-to-sales valuation reflects market expectations, with the 27.50 mark capturing this metric. The business's financial success relies on Chinese demand for brachytherapy equipment and the regular supply of isotopes.

Pheton - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep PTHL (periode 06.09.2024 - 16.01.2026)

PTHL (Pheton Holdings Limited): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:Pheton Holdings (PTHL)
Produk asli Pheton Holdings

This indicator reflects the market value of the business relative to expected revenue, accounting for the cost of capital and allowing for an assessment of the risk of overpaying for future cash flows. By analyzing the forward P/S valuation, an investor can compare the current discount with the pace of Pheton Holdings Ltd (PTHL) restructuring and the implementation of transparent reporting standards, which should mitigate the risk of share write-downs amid changing interest rates.

Pesaing wigati

Multiplikator Forward P/S HLN (Haleon PLC)|Multiplikator Forward P/S Kenvue Corp KVUE|Verona Pharma PLC - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep jyongbio.com|LGND: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan AMRX|Rasio rega marang prakiraan pendapatan Perrigo Company|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alvotech ALVO|Multiplikator Forward P/S LQDA|GLPG: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S ANIP (ANI Pharmaceuticals, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake MannKind Corp (MNKD)|AMPH: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan TBPH|AQST (Aquestive Corp) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan scPharmaceuticals Inc. (SCPH)|Multiplikator forward rega marang pendapatan TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan SXT Pharmaceuticals SXTC|Rega forward marang dodolan EPRX|BHST - Rasio rega marang prakiraan pendapatan|eXoZymes (EXOZ) - Multiplikator forward rega marang pendapatan|ORMP: Multiplikator Forward P/S|ENTX: Rasio rega marang pendapatan sing dikarepake|HYFT (ipatherapeutics.com) - Multiplikator Forward P/S|Multiplikator Forward P/S ABVC BioPharma|Rasio rega marang prakiraan pendapatan Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Rega forward marang dodolan|Multiplikator Forward P/S FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|RANI - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Synergy CHC SNYR|RLYB: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Lexaria (LEXX)|Rasio rega marang prakiraan pendapatan Pulmatrix|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aptorum Group Limited APM|Rasio rega marang prakiraan pendapatan Lyra Therapeutics (LYRA)|Multiplikator forward rega marang pendapatan Impact BioMedical Inc IBO|Rasio rega marang prakiraan pendapatan tnfpharma.com TNFA|Rega forward marang dodolan YCBD|PainReform Ltd - Multiplikator Forward P/S|Altamira Therapeutics Ltd (CYTO) - Multiplikator forward rega marang pendapatan|lipella.com (LIPO) - Rasio rega marang prakiraan pendapatan|OptiNose (OPTN) - Multiplikator Forward P/S|PIRS (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|PROC: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Petros Pharmaceuticals, Inc. (PTPI)|Multiplikator Forward P/S Qilian International Corp (QLI)|ACELYRIN, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S tffpharma.com TFFP